Aug 2020

An Introduction to the

Catapult Network

2

THE CATAPULT NETWORKA world-leading national capability

The Catapult Network supports businesses in transforming great ideas into valuable products and services, through cutting-edge R&D infrastructure. We are a network of world-leading technology and innovation centresestablished by Innovate UK. As independent non-for-profit organisations, we deliver impact across the UK economy, enabling businesses to thrive in global markets.

30 locations and expanding reach through partnerships with universities, all

levels of government and a wide range of enterprise partners

3

GROWING MARKETS

AND INDUSTRIES

Knowledge,

infrastructure and

collaborations to make

today’s industry more

productive, and create

tomorrow’s markets

OUR PURPOSE

OUR MISSIONAccess to world-class unique R&D infrastructure, expertise and capabilities

Collaboration building between businesses, their supply chains, academia, charities, service providers, end-users and others

Development and deployment of innovative solutions to accelerate commercialisation and value chains

Working with innovators and

industry to prove and adopt

breakthrough products,

processes, services and

technologies

4

LEVERAGE & IMPACT

Generating Revenue, Productivity, Jobs, Exports, FDI, Skills …

Maximised UK productivity and global competitiveness in key industries through applied innovation

Contributing towards 2.4% of GDP invested in R&D

Core grant

investment in

capability

Attracts commercial

investment in

projects

£200m

£471m

£338m

£Xx

Wins

collaborative

R&D

Industry R&D linked

to Catapult activity

Total related CR&D

£697m

In 2018/19

>£1.1bnAssets

OUR VISION

A TRUSTED PARTNER

Facilitate, galvanise and

support industries to grow

and realise the UK’s economic

ambitions

Work with policy makers, industry and regulators to

reduce and overcome barriers

Mobilisestakeholders to

create an attractive R&D environment

anchoring inward investment

Shape and build a positive

environment for innovation,

drawing on the UK research

base

Stimulate demand and unlock new

markets

5

TAILORED BUSINESS SUPPORT

Toolkits and transferable methodologies to investigate, evaluate and improve products, processes and technologies

Advice about business and workforce development, commercialisation and investment

Growth accelerator and incubator programmes, scale up and routes to finance

Routes to international export of professional and technical services

CATAPULTS AT THE CENTRE OF UK INDUSTRIAL STRATEGY

Medicines Manufacturing

Faraday Battery Challenge

Driving the Electric Revolution

Prospering from the Energy Revolution

Manufacturing Made Smarter

AI and Robotics

A key partner in addressing major industry challenges

Audience of the Future

Next Generation Services

Clean Growth

Ageing Society

AI and Data

6

The Nine Catapults

7

Development laboratories

• 1200m2 purpose built centre

• Analytical characterisation

• Process development

• Viral vector

7,700m2 Manufacturing

Centre

• Specifically designed for cell

and gene therapies

• 12 segregated large

cleanroom modules

• Unique collaborative

operating model

• central to the development of

the third largest cell and gene

therapy cluster globally

It is our vision for the

UK to be a global leader

in the development,

delivery and

commercialisation of

cell and gene therapies.

Where businesses can

start, grow and

confidently develop

advanced therapies,

delivering them to

patients rapidly and

effectively.

Cell and Gene Therapy Catapult

Two MHRA licences awarded for

collaborating companies to produce living

medicines at scale. Autolous are now

producing therapies for clinical trials. TCR2

Therapeutics (from US) established

operations at the centre to produce novel

cancer therapies.

SME collaborators have raised £1bn in

investment, whilst the sector has seen the

creation of 1500 jobs, company numbers

grow from 22 to 70, clinical trials from 21 to

93, driving new therapies and on track to

creating 18,000 jobs by 2035.

Two MHRA licences awarded for

collaborating companies to produce living

medicines at scale. Autolus are now

producing therapies for clinical trials in UK

and US. TCR2 Therapeutics (a US company)

established operations at the centre to

produce novel cancer therapies.

SME collaborators have raised £1bn in

investment, whilst the sector has seen the

creation of 1500 jobs, company numbers

have grown from 22 to over 90, clinical trials

from 21 to 126, driving new therapies and on

track to creating 18,000 jobs by 2035.

8

Creating a collaborative

innovation centre within

the world’s compound

semiconductor cluster in

South Wales.

Our vision is for the UK to

become a global leader in

developing and

commercialising new

applications for compound

semiconductors.

design studio

• simulation tools

• industry collaboration

class 10K advanced packaging lab

• materials characterisation

• precision engineering

• die preparation & hybrid integration

power electronics lab

• power device characterisation & modelling

• access to 100KW to 300KW of power

• EMC screened

RF/microwave lab

• device characterisation

• harsh environment analysis

photonics & sensors lab

• advanced metrology

• dark room

facility

• 30,000 sq. ft

The Compound Semiconductor Applications

Catapult, having just established its

innovation centre, is working with industry

partners to create a unique UK Silicon

Carbide supply chain for Vehicle

Electrification, from fabrication to

deployment, as part of the £20m ESCAPE

(End to End Supply Chain Development for

Automotive Power Electronics) consortium.

This will produce game-changing technology

to drive electrification in the UK and

worldwide.

Compound Semiconductor

Applications Catapult

9

Capabilities & Expertise

• Urban IoT

• Market Analysis & Strategy

• Standards

• Visual & Urban Design

• Architecture & Engineering

• Economics

• Software development

• Connected & Autonomous Vehicles

• Drone & Aviation

• Business & Economist Modelling

• Systems Architecture & Data

• Human Factors & Anthropology

• Customer Insight

• Air quality & Pollution

• Systems Development

The Connected Places Catapult

accelerates smarter living and

travelling in and between the

places of tomorrow.

Our vision is for the UK to lead

the world in creating cities, towns

and places which thrive on their

ability to connect people to

resources, opportunities, ideas

and each other. Where the smooth

flow of people, goods,

transportation and services,

drives economic success,

productivity and wellbeing.

Connected Places Catapult has been supporting a

successful City Region Deal in Belfast which was

awarded £500m and is expected to deliver £2

billion in additional GVA and 10,000 new jobs,

including over £150m of private investment from

major companies in the region.

It has also been instrumental in the UK developing

world leading Connecting and Autonomous

vehicle technology, including overseeing the

ground breaking LUTZ pathfinder Pod project,

generating £435m in additional investment and

£110m worth of global media coverage.

Connected Places Catapult

10

Technologies

• Future Networks

5G, Low Powered Wide Area

Networks, Internet of Things

• Immersive Technologies

Virtual Reality, Augmented Reality,

Mixed Reality, Haptics

• Artificial Intelligence and Machine

Learning

• Future Focus

Cybersecurity and testing

Distributed ledger (blockchain)

outside finance

Sectors

• Manufacturing

• Creative Industries

The UK’s leading advanced

digital technology innovation

centre

Accelerating the early

adoption of advanced digital

technology. Making UK

businesses more competitive

and productive to grow the

country’s economy.

Digital Catapult’s open access low-power wide-

area networks (LPWAN) testbed is helping UK

Sigfox operator, WNDUK roll-out its

narrowband network to achieve 95% UK

population coverage by 2019. This has

accelerated access to deployment sites,

funding and connections, benefitting over 50

startups and scaleups.

Digital Catapult has been critical in fast tracking

development of the resulting Internet of Things

products and services.

Digital Catapult

11

Capabilities and Assets

• Modelling: energy systems, storage

and flexibility modelling and analysis

• Consumer Insight: research,

design, trials

• Digital and data: digital and data

systems, AI and data science, Living

Lab

• Systems Integration: systems

engineering, architecting and

simulation, with business model

innovation

• Infrastructure and Engineering:

renewables, nuclear, networks, CCS,

energy storage, bioenergy hydrogen

and transport

• Markets, Policy and Regulation

Unleashing innovation and

open new markets to capture

the clean growth opportunity

Accelerating the transformation

of the UK’s energy system and

ensure UK businesses and

consumers capture the

opportunities of clean growth.

It takes a whole systems view of

the energy sector, helping us to

identify and address innovation

priorities and market barriers to

decarbonise the energy system at

least cost.

Energy Systems Catapult has developed a national

asset called the ‘Living Lab’ - a 100 home test and

demonstration environment for businesses to trial

new energy products and services in homes

retrofitted with room-by-room sensors and smart

heating controls. By trialling with real people,

including vulnerable households, businesses can

rapidly design, market-test and launch innovations

that give consumers better control over cost and

comfort, and scale for low carbon technology.

Energy Systems Catapult

12

A £780m asset base across 7

centres of innovation excellence in

18 locations

Main technology areas

• Digital manufacturing

• Robotics and automation

• Materials processing and new

materials

• Process engineering,

biotechnology and biologics

• Product design and verification

Driving growth of

manufacturing

Our strategy is to grow the

UK’s advanced

manufacturing value add by

helping industry to develop

new manufacturing

technology.

We will create the conditions

for economic growth by

enabling UK manufacturers to

achieve significant

improvements in their

performance and

productivity.

Improving Productivity

HVM Catapult Advanced Manufacturing

Research Centre (AMRC) helped transform

Rolls Royce’s productivity in disc machining –

reducing the manufacture time by 50% -

helping improve cost competitiveness and to

secure a £100m investment in a new disc

manufacturing facility in Tyne & Wear.

The same know-how also attracted Boeing to

establish its only European manufacturing

facility in the UK producing components more

cost effectively than at its Mexican operation.

The expertise of engineers from our

Advanced Manufacturing Research Centre

(AMRC) with Boeing has enabled our

industry partner, Rolls-Royce, to reduce the

production time and increase performance

when

manufacturing key components, called aero-

engine discs.

High Value Manufacturing Catapult

13

Medicines Discovery Catapult

Capabilities• Syndicates – Innovative model for

patient-focussed, collaborative drug

discovery

• Virtual R&D – Expert advice, programme

management, discovery services

network

• Discovery Technologies

• Drug Delivery / Biodistribution

• Biomarkers

• Target & Pathway Engagement

• Cell Model Analysis & Validation

• Patient Sample Access

• Informatics – Data/Information search,

Intelligent capture, Analysis and

Interpretation

Collaborators

• SMEs, Academics, Biotechs, Charities,

Contract Research Organisations

(CROs), Large Pharma and Technology

companies

At Medicines Discovery

Catapult, we are

reshaping the UK’s

drug-discovery industry

Our Mission is to

industrialise & drive

adoption of

breakthrough

approaches that

discover patient-

centered medicines,

faster

Improving the productivity

and fundability of

medicines discovery

assets in the UK

MS is a devastating, debilitating disease.

To enable new treatments to reach patients faster, the MS

Society wanted to identify existing treatments that could

be repurposed for use in MS. A list of potential candidates

was compiled by an expert consortium.

Using a data-driven approach and machine learning

techniques, MDC supported this strategic drug

prioritisation exercise by compiling an independent list.

This project verified the expert generated list and

identified ~300 further potential candidates for

investigation.

Ultimately, MDC provided confidence that the drug

candidates selected to clinical trials had the best chance

of success and the potential to provide patients with

better treatments faster.

“It has been a pleasure working with MDC on this

project, which has given the MS Society an opportunity

to utilise the impressive informatics skills and

capabilities at MDC to complement our work. Our

treatment selection initiative is focussed on achieving

impact for people affected by MS through accelerating

the development of treatments and MDC have been an

effective responsive and collaborative partner in

helping us make progress.”

Dr Sorrell Bickley

Head of Biomedical Research, MS Society

Using a data-driven approach to

identify drug candidates for

Multiple Sclerosis

14

Unique facilities, research &

engineering capabilities

bringing together industry and

academia

We deliver:▪ Research

▪ Innovation

▪ Test & Validation

▪ Supply Chain growth

Our facilities

• Turbine blade testing

• Powertrain test rigs

• High Voltage testing lab

• Marine test docks

• 7MW offshore research turbine

• Offshore anemometry hub

Accelerating the creation

and growth of UK

companies in the offshore

renewable energy sector,

enabling the transition to

a low carbon economy

Our vision:

To be the world’s leading

offshore renewables

technology centre.

Offshore Renewable Energy Catapult has launched

its Fit for Offshore Renewables (F4OR) programme,

in partnership with the High Value Manufacturing

Catapult. This programme allows companies to

measure the standards of their operations against

industry requirements standards and to take steps to

close the gap. This is helping the UK supply chain

prepare for the grow of the industry and already

helping companies win new contracts as a result.

The Catapult is also delivering a £100m supply chain

growth programme on behalf of the industry, to help

UK companies seeking to grow their business in this

rapidly-growing global market.

Offshore Renewable Energy Catapult

15

Our vision:

To be a world-leading

innovation and technology

company, helping

businesses of all sizes to

realise the potential from

space.

To innovate for a better world, empowered by satellites.

Integration for a connected

and information centric

world

Facilities

• Disruptive Innovation for Space

Centre, for rapid-prototyping and

manufacturing

• 5G test-bed

• Business incubation centre

• In-orbit servicing and satellite

operations centre

MarketsUbiquitous Connectivity

Geospatial Innovation

Access to Space

Satellite enabled applications in:

• Agriculture

• Extractive Industries

• Health & Wellbeing

• Transport & Infrastructure

• Sustainable Finance

Bringing space to UK companiesSatellite Applications Catapult’s In Orbit

Demonstration (IOD) programme offers companies

a fast track, low cost opportunity to test a service or

technology in orbit. This is enabling US Orbital

Micro Systems (OMS) to move operations to the UK

with new commercial opportunities in aerospace,

maritime transportation, agriculture, insurance and

energy.

Satellite Applications A partnership with Highlands & Islands Enterprise

(HIE) and Corporate Health International is helping

detect bowel disease using satellite-enabled Video

Capsule Endoscopy. A tiny video capsule consumed

orally by patients, uses satellite technology to

upload data and images for consultants to review,

reducing the need for travel and invasive

procedures.

Satellite Applications Catapult

catapult.org.uk